News Release

View printer-friendly version
<< Back

DURECT Corporation to Present at the Security Research Associates' Spring Technology & Life Sciences Investor Conference


CUPERTINO, Calif., Feb 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the Security Research Associates Spring Technology & Life Sciences Investor Conference at the Campton Place Hotel in San Francisco. Dr. James E. Brown, President and Chief Executive Officer, will be presenting at the conference on Monday, February 28, 2005 at 11:30 a.m. PST.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceuticals systems company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies that treat chronic debilitating diseases and enable biotechnology products. These platform technologies include the SABER(TM) Delivery System (a patented and versatile depot injectable useful for protein and small molecule delivery), the ORADUR(TM) sustained release oral gel-cap technology (an oral sustained release technology with several potential abuse deterrent properties), the DURIN(TM) Biodegradable Implant (drug-loaded implant system), the TRANSDUR(TM) transdermal technology and the MICRODUR(TM) Biodegradable Microparticulates (microspheres injectable system). DURECT also partners with pharmaceutical companies to develop and commercialize proprietary and enhanced pharmaceutical products based on its technologies. DURECT has five disclosed on-going development programs of which three are in collaboration with pharmaceutical partners. Additional information about DURECT is available at www.durect.com.

NOTE: SABER(TM), ORADUR(TM), DURIN(TM), TRANSDUR(TM) and MICRODUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.

SOURCE DURECT Corporation

Schond L. Greenway (investors), Executive Director, IR and Strategic Planning, 408-777-1417, or
Melissa M. Ta (media), Associate Director, Corporate Communications, 408-777-1417,
both of DURECT Corporation

http://www.prnewswire.com